Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| CBIO | NASDAQ | Crescent Biopharma, Inc. | $12.76 | -0.47% | 211K | $473.96M |
| EOLS | NASDAQ | Evolus, Inc. | $7.17 | +2.28% | 430K | $473.58M |
| MNPR | NASDAQ | Monopar Therapeutics Inc. | $70.54 | -0.16% | 79K | $473.48M |
| ARVN | NASDAQ | Arvinas, Inc. | $7.31 | +0.14% | 725K | $471.65M |
| DMAC | NASDAQ | DiaMedica Therapeutics Inc. | $8.74 | +0.23% | 130K | $471.31M |
| KMDA | NASDAQ | Kamada Ltd. | $7.94 | +2.19% | 70K | $458.09M |
| PROK | NASDAQ | ProKidney Corp. | $1.36 | -3.55% | 761K | $457.31M |
| EPRX | NASDAQ | Eupraxia Pharmaceuticals Inc. | $6.85 | -0.29% | 540K | $452.6M |
| NPCE | NASDAQ | NeuroPace, Inc. | $12.99 | +0.62% | 67K | $445.87M |
| MCTA | NASDAQ | Charming Medical Limited Class A Ordinary Shares | $29.36 | 0.00% | 0 | $445.55M |
| BWAY | NASDAQ | BrainsWay Ltd. | $11.21 | -0.36% | 75K | $439.69M |
| RGNX | NASDAQ | REGENXBIO Inc. | $6.58 | -1.50% | 1.1M | $434.37M |
| FTH | NASDAQ | Faeth Therapeutics, Inc. | $16.83 | -1.46% | 424K | $433.86M |
| PRTA | NASDAQ | Prothena Corporation plc | $8.40 | +2.44% | 595K | $431.23M |
| AGMB | NASDAQ | AgomAb Therapeutics N.V. American Depositary Shares | $8.57 | -5.30% | 74K | $422.06M |
| SRTA | NASDAQ | Strata Critical Medical, Inc. | $4.76 | +2.15% | 460K | $421.1M |
| OVID | NASDAQ | Ovid Therapeutics Inc. | $2.16 | -0.23% | 844K | $420.87M |
| ALLO | NASDAQ | Allogene Therapeutics, Inc. | $1.21 | -3.20% | 10.6M | $418.04M |
| AUTL | NASDAQ | Autolus Therapeutics plc | $1.53 | -0.65% | 1.2M | $407.22M |
| CARL | NASDAQ | Carlsmed, Inc. | $14.91 | +2.62% | 109K | $407.08M |
| ASMB | NASDAQ | Assembly Biosciences, Inc. | $19.67 | -0.86% | 152K | $400.49M |
| ALT | NASDAQ | Altimmune, Inc. | $2.05 | -3.30% | 3.5M | $398.76M |
| SENS | NASDAQ | Senseonics Holdings, Inc. | $7.48 | -0.40% | 489K | $395.5M |
| OFIX | NASDAQ | Orthofix Medical Inc. | $9.78 | -0.31% | 201K | $395.32M |
| TECX | NASDAQ | Tectonic Therapeutic, Inc. | $19.95 | -0.60% | 151K | $390.01M |
| SPRY | NASDAQ | ARS Pharmaceuticals, Inc. | $3.92 | -2.73% | 1.4M | $389.83M |
| EMBC | NASDAQ | Embecta Corp. | $6.80 | +1.34% | 679K | $385.29M |
| INDP | NASDAQ | Indaptus Therapeutics, Inc. | $3.34 | +5.70% | 353K | $378.23M |
| RCEL | NASDAQ | Avita Medical Inc. | $15.18 | -2.13% | 323K | $377.12M |
| YDES | NASDAQ | YD Bio Limited Ordinary Shares | $5.29 | +6.87% | 59K | $374.7M |
| NGNE | NASDAQ | Neurogene Inc. | $23.54 | -0.04% | 123K | $371.99M |
| VMD | NASDAQ | Viemed Healthcare, Inc. | $9.73 | -0.71% | 157K | $370.6M |
| RZLT | NASDAQ | Rezolute, Inc. | $3.82 | -0.91% | 1.5M | $369.48M |
| EDIT | NASDAQ | Editas Medicine, Inc. | $2.40 | +0.19% | 1.4M | $368.59M |
| CV | NASDAQ | CapsoVision, Inc. | $6.89 | -1.43% | 105K | $366.62M |
| CCCC | NASDAQ | C4 Therapeutics, Inc. | $2.98 | -2.61% | 3.2M | $366.61M |
| AVTX | NASDAQ | Avalo Therapeutics, Inc. | $6.77 | -2.31% | 2.4M | $363.08M |
| MOBI | NASDAQ | Mobia Medical, Inc. Common Stock | $10.73 | +3.07% | 202K | $357.21M |
| FENC | NASDAQ | Fennec Pharmaceuticals Inc. | $10.15 | +0.69% | 116K | $355.93M |
| TKNO | NASDAQ | Alpha Teknova, Inc. | $6.59 | +2.65% | 678K | $353.81M |
| ENTA | NASDAQ | Enanta Pharmaceuticals, Inc. | $12.00 | +3.09% | 441K | $349.5M |
| RLMD | NASDAQ | Relmada Therapeutics, Inc. | $3.23 | -1.22% | 776K | $344.54M |
| ZURA | NASDAQ | Zura Bio Limited | $3.56 | +5.95% | 4.3M | $341.15M |
| AVIR | NASDAQ | Atea Pharmaceuticals, Inc. | $4.16 | +2.97% | 251K | $333.65M |
| OBIO | NASDAQ | Orchestra BioMed Holdings, Inc. | $5.55 | -0.72% | 243K | $333.58M |
| CAPR | NASDAQ | Capricor Therapeutics, Inc. | $5.74 | -3.20% | 1.5M | $332.41M |
| MPLT | NASDAQ | MapLight Therapeutics, Inc. | $7.66 | -3.89% | 252K | $326.46M |
| KYTX | NASDAQ | Kyverna Therapeutics, Inc. | $5.27 | -2.23% | 810K | $325.91M |
| XFOR | NASDAQ | X4 Pharmaceuticals, Inc. | $3.25 | +0.31% | 702K | $322.23M |
| TTRX | NASDAQ | Turn Therapeutics Inc. | $10.61 | +3.21% | 96K | $322.2M |
50 Healthcare Companies
Review companies currently returned for the Healthcare screen, with price, performance, volume and market-cap context.
How This Sector Screen Works
Results are loaded from current company data and can be narrowed by exchange or company search without changing the canonical sector page.
About the Healthcare Sector
The Healthcare classification groups companies with related business activities so investors can compare peers within a common market segment.
Related Sector Screens
Return to the screener directory to compare this sector with daily movers and the other industry groups covered by Cashu Finance.